ダウンロード数: 829

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
adfm.201502139.pdf804.88 kBAdobe PDF見る/開く
タイトル: Induction of Potent Antitumor Immunity by Sustained Release of Cationic Antigen from a DNA-Based Hydrogel with Adjuvant Activity
著者: Umeki, Yuka
Mohri, Kohta
Kawasaki, Yohji
Watanabe, Hiroshi
Takahashi, Rei
Takahashi, Yuki  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0002-8772-2772 (unconfirmed)
Takakura, Yoshinobu  KAKEN_id  orcid https://orcid.org/0000-0002-7359-2647 (unconfirmed)
Nishikawa, Makiya
著者名の別形: 西川, 元也
キーワード: cationization
controlled release
DNA
hydrogels
immune cells
発行日: Sep-2015
出版者: Wiley
誌名: Advanced Functional Materials
巻: 25
号: 36
開始ページ: 5758
終了ページ: 5767
抄録: Previous studies indicate that immunostimulatory DNA-based injectable hydrogels harboring unmethylated cytosine-phosphate-guanine (CpG) dinucleotides meet the requirements of an effective antigen delivery system, including safety, biodegradability, ease of administration, and stimulation of the innate immune system. However, rapid release of the model antigen ovalbumin (OVA) from the hydrogel limits its potential. Here, the aim is to achieve sustained OVA release from a DNA hydrogel through cationization of the antigen. Ethylenediamine (ED)-conjugated cationized OVA (ED-OVA), but not OVA, forms a complex with hexapod-like structured DNA, a component of the DNA hydrogel. The release of ED-OVA from the hydrogel is significantly slower than that of OVA. ED-OVA mixed with CpG DNA hydrogel efficiently binds to mouse dendritic DC2.4 cells and results in high antigen presentation. Intratumoral injections of ED-OVA/CpG DNA hydrogel significantly delays tumor growth of OVA-expressing EG7-OVA cells in mice. Then, a cationic OVA peptide antigen (R8-L2-pepI) consisting of an OVA MHC class I epitope, octaarginine, and a linker is designed. Intratumoral injections of R8-L2-pepI/CpG DNA hydrogel eradicate tumors in five out of six mice. Thus, it is concluded that a vaccine consisting of immunostimulatory CpG DNA hydrogel and cationized antigens can be effective for cancer immunotherapy.
記述: Article first published online: 13 AUG 2015
著作権等: This is the peer reviewed version of the following article: Umeki, Y., Mohri, K., Kawasaki, Y., Watanabe, H., Takahashi, R., Takahashi, Y., Takakura, Y. and Nishikawa, M. (2015), Induction of Potent Antitumor Immunity by Sustained Release of Cationic Antigen from a DNA-Based Hydrogel with Adjuvant Activity. Adv. Funct. Mater., 25: 5758–5767, which has been published in final form at http://dx.doi.org/10.1002/adfm.201502139. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
The full-text file will be made open to the public on 13 AUG 2016 in accordance with publisher's 'Terms and Conditions for Self-Archiving'.
This is not the published version. Please cite only the published version.
この論文は出版社版でありません。引用の際には出版社版をご確認ご利用ください。
URI: http://hdl.handle.net/2433/202594
DOI(出版社版): 10.1002/adfm.201502139
出現コレクション:学術雑誌掲載論文等

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。